Skip to main content
€

Or 34,00€ After 66% tax deduction

I make a monthly donation I make an IFI donation
Mur d'écrans de télévision

Press Room

Resources dedicated to journalists and media professionals

The PR department responds to all media requests for information on scientific, medical, technological and entrepreneurial activities at Paris Brain Institute.

It disseminates new results from research teams and connects journalists to a relevant expert to comment on a current issue.

Feel free to contact our press officer to help you develop a topic that relies on state-of-the-art knowledge in neuroscience, neurology or psychiatry.

Press contact
Marie Simon
Email : presse@icm-institute.org

Our press documents

image
New drug candidate slows the progression of adrenoleukodystrophy
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023 Research, science & health
image dépression
Ketamine and depression: a mechanism of the antidepressant effect reveal
Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
10.06.2022 Research, science & health

Our useful documents

News that might interest you

Les ondes lentes de l’éveil
Sleep-like slow waves: early sentinels of Alzheimer’s disease?
What if the risk of developing Alzheimer’s disease could be assessed with an EEG? Pierre Champetier and his colleagues in the DreamTeam think the idea is worth taking seriously. In a study published in Alzheimer’s & Dementia, the team shows that slow...
09.07.2026 Research, science & health
Hypertension intracrânienne idiopathique
Idiopathic intracranial hypertension: the role of cerebral venous flow revealed
Sometimes, doctors cannot find the cause of intracranial hypertension, a syndrome characterized by excess pressure inside the skull. Patients’ symptoms are effectively relieved by a procedure that dilates a vein in the brain… yet no one truly...
07.22.2026 Research, science & health
motoneurones
Parkinson's disease, multiple sclerosis, ALS: behind the rising case numbers, distinct dynamics
The number of patients living with neurodegenerative diseases that affect movement is rising steadily across Europe. Yet a large-scale study from the Paris Brain Institute and the Karolinska Institutet in Stockholm shows that this is not an emerging...
06.08.2026 Research, science & health
L'équipe Cure-ND4ALS
European CURE-ND alliance launches the CURE-ND4ALS initiative in order to speed up translational research into Charcot’s disease (ALS)
The European CURE-ND alliance has announced the launch of CURE-ND4ALS, an ambitious, patient-focused initiative that seeks to tackle amyotrophic lateral sclerosis (ALS). The program is supported by Fonds Invincible Été, a philanthropic fund...
05.29.2026 Institutional
Microtubules in vitro. Crédit : Paul Appleton, Université de Dundee.
When physics sheds new light on brain diseases
For decades, cell biology has built its approach around the study of genes and molecules, pushing the physical forces that sculpt our tissues into the background. Today, an international consortium, coordinated by Fanny Mochel at the Paris Brain...
05.26.2026 Research, science & health
Rêver éveillé : les états oniriques ne sont pas réservés au sommeil
Dreaming while awake: dream-like states are not confined to sleep
We tend to take for granted that the thoughts associated with sleep have a particular quality: we often describe them as elusive, abstract, or marked by a certain strangeness. Yet a study conducted by researchers from the DreamTeam at the Paris Brain...
04.29.2026 Research, science & health
See all our news